Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infants' and Children's Tylenol recall

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare recalls 57 lots of Children's and Infants' Tylenol liquid products due to possible bacterial contamination detected in testing of bulk raw material performed after the products were shipped. The Johnson & Johnson subsidiary said Sept. 24 a portion of the supply of one of the products' inactive ingredients not used during manufacturing between April 2008 and June 2008 "did not meet internal testing requirements," although the acetaminophen products now on recall "met all specifications" before being shipped to retailers. According to a statement, Fort Washington, Pa.-based McNeil consulted with FDA and agreed to a voluntary recall at the warehouse and retail levels even though "the likelihood of a serious medical event is remote." The recalled products include select lots of Children's and Infants' Tylenol liquid and do not include the Meltaways delivery form, McNeil said. A full list appears on McNeil's 1Web site
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS103366

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel